↓ Skip to main content

The effect of natalizumab on disability score and relapse rate of multiple sclerosis patients: a prospective cohort study

Overview of attention for article published in Clinical and Translational Medicine, November 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
5 tweeters

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
12 Mendeley
Title
The effect of natalizumab on disability score and relapse rate of multiple sclerosis patients: a prospective cohort study
Published in
Clinical and Translational Medicine, November 2018
DOI 10.1186/s40169-018-0216-3
Pubmed ID
Authors

Mehrdokht Mazdeh, Shno Hosseini, Mohammad Taheri, Soudeh Ghafouri‐Fard

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 17%
Researcher 2 17%
Student > Postgraduate 2 17%
Student > Doctoral Student 1 8%
Student > Master 1 8%
Other 3 25%
Unknown 1 8%
Readers by discipline Count As %
Neuroscience 5 42%
Medicine and Dentistry 4 33%
Nursing and Health Professions 1 8%
Engineering 1 8%
Unknown 1 8%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 January 2019.
All research outputs
#6,867,429
of 21,196,061 outputs
Outputs from Clinical and Translational Medicine
#169
of 647 outputs
Outputs of similar age
#164,141
of 423,302 outputs
Outputs of similar age from Clinical and Translational Medicine
#13
of 27 outputs
Altmetric has tracked 21,196,061 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 647 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 423,302 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.